Heterofunctional cellular immunological reagents, vaccines conta

Details Heterofunctional cellular immunological reagents, vaccines conta Heterofunctional cellular immunological reagents, vaccines conta

1995-06-06

2000-08-01

Stucker, Jeffrey

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4241841, 4241851, 530350, 530395, 530403, 530868, C07K 100

Patent

active

060963158

ABSTRACT:
The present invention relates to a heterofunctional cellular immunological reagent comprising at least two T cell specific binding ligands covalently linked together, wherein one of the T cell specific binding ligands binds to a specific class or subclass of T cells and another of the T cell specific binding ligands is an antigen associated with disease or a causative agent of disease, or epitope thereof. The present invention also relates to vaccines containing the heterofunctional cellular immunological reagents and methods for the use of the same.

REFERENCES:
patent: 4400376 (1983-08-01), Sanderson
patent: 4478823 (1984-10-01), Sanderson
patent: 4599230 (1986-07-01), Milich et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4605512 (1986-08-01), Schaller et al.
patent: 4681760 (1987-07-01), Fathman
patent: 4683136 (1987-07-01), Milich et al.
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4822606 (1989-04-01), Snyderman et al.
patent: 4835255 (1989-05-01), Weissman et al.
Bretimeyer, J. B., Nature 329:760-761, How T cells communicate, Oct. 1987.
Kennedy, R. C. et al., Science 231:1556-9, Antiserum to a syntehtic peptide recognizes the HTLV-III envelope glycoprotein, Oct. 1986.
Fudenberg, H, H., et al. (ed) Basic and Clinical Immunology, 3rd edtion, pp. 44-52, LANGE Medical Pulications, Los Altos, CA, 1980.
K. Gokulan, et al., Bioactive Fragment of Human IL-1.beta. [163-171] . . . , Microbiol. Immunol., 41(12), 965-974, 1997.
K. Rao, et al., Enhanced immunogenicity of a sequence derived from . . . , Proc. Natl. Acad. Sci. USA, vol. 87, pp. 5519-5522, Jul. 1990.
Guillet et al, Science, 235(4791):865-870 (1987).
Guillet et al, Nature, 324:260-262 (1986).
Shimonkevitz et al, J. Immunol., 133(4):2067-2074 (1984).
Berkower et al, J. Immunol., 136(7):2498-2503 (1986).
Humpfrey, "Regulation of In Vivo Immune Responses: Few Principles and Much Ignorance", Synthetic Peptices as Antigens, John Wiley and Sons, New York.
Byers et al, Basic and Clinical Immunology, pp. 296-305 (1980).
Carbone et al, In: Fundamental Immunology, pp. 541-544 (1989).
Weiss, In: Fundamental Immunology, pp. 359-369 (1989).
Maloy, Immunol. Res., 6:11 (1987).
Margulies et al, Immunol. Res., 6:101 (1987).
McCluskey et al, J. Immunol., 136:1472 (1986).
Germain et al, Ann. Rev. Immunol., 4:281 (1986).
Bluestone, Immunol. Res., 6:67 (1987).
McCluskey et al, J. Immunol., 137:3881 (1986).
Ozato et al, J. Immunol., 137:3881 (1986).
Fremont et al, Science, 257:919 (1992).
Swain, Proc. Nat. Acad. Sci., 78:7101 (1982).
Goldstein et al, J. Immunol., 140:3707 (1988).
Potter et al, J. Exptl. Med., 166:956 (1987).
Guann et al, J. Virol., 61:2639 (1987).
Nencioni et al, J. Immunol., 139:800 (1987).
Lui et al, Science, 239:395 (1988).
Bert et al, Eur. J. Immunol., 17:437 (1987).
Bert et al, Molec. Immunol., 24:379 (1987).
Chretien et al, J. Immunol., 141:3129 (1988).
Palker et al, Proc. Nat. Acad. Sci., 85:1932 (1988).
Connolly et al, J. Exptl. Med., 168:325 (1988).
Potter et al, Nature, 337:73 (1989).
Connolly et al, Proc. Nat. Acad. Sci., 87:2137 (1990).
Salter et al, Nature, 345:41 (1990).
Cammarota et al, Nature, 356:799 (1992).
Nissen et al, J. Immunol., 139:1022 (1987).
Parham et al, J. Biol. Chem., 258:6179 (1983).
Van den Elsen et al, J. Immunol. Meth., 112:15 (1988).
Streicher et al, Proc. Nat. Acad. Sci., 81:6831 (1983).
Parham et al, Nature, 325:625 (1987).
Clayberger et al, Nature, 330:763 (1987).
Claman, J. Amer. Assoc., 258:2834 (1987).
Good et al, Science, 235:1059-1062 (1987).
Pierschbacher et al, Cell, 26:259 (1981).
Mazerolles et al, Cell, 56:497 (1988).
D'Souza et al, Science, 242:91 (1988).
Loftus et al, Science, 249:915 (1990).
Ferguson et al, Proc. Nat. Acad. Sci., 88:8072 (1990).
Sherman et al, Science, 258:815 (1992).
Matsumura et al, Science, 257:927 (1992).
Fourth Edition of the "Sequences of Proteins of Immunological Interest", pp. 337-348, edited by E.A. Kabat et al (1987) and published by the U.S. Dept. of Health and Human Services.
Jolivet et al, Infect. Immun., 55:1498-1502 (1987).
Leo et al, J. Immunol., 139:3556-3563 (1987).
Francis et al, Nature, 330:168-170 (1987).
Beachey et al, Exp. Med., 166:647-656 (1987).
Ozaki et al, J. Immunol., 138:4133-4142 (1987).
Milich et al, Proc. Nat. Acad. Sci. USA, 85:1610-1614 (1988).
Schrier, et al., The Journal of Immunology, T Cell Recognition Of HIV Synthetic Peptides . . . , vol. 142, 1166-1176, No. 4, Feb. 15, 1989.

Affiliated with

Also associated with

Rating

Heterofunctional cellular immunological reagents, vaccines conta does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterofunctional cellular immunological reagents, vaccines conta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterofunctional cellular immunological reagents, vaccines conta will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-661034